Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The effectiveness of statins for women with PCOS is unclear.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

A Shi Tzu dog with high cortisol levels improved after increasing the dose of trilostane.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

GI197111X is best dissolved in Capmul MCM for trials.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Baricitinib shows promise in treating severe hair loss.

Lithium poisoning can cause severe health complications and requires careful monitoring.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Trilostane generally improved symptoms in dogs with Cushing's syndrome, but dosage adjustments were needed over time.

Gabapentin may help relieve itchy scalp in lichen planopilaris patients.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

These new skin treatments are safer and more effective with minimal side effects.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

A girl's hair loss from a pharmacy error improved after getting the right medicine.

Valproic acid treatment may cause hair loss due to reduced biotinidase activity.

Oral dexamethasone may help regrow hair in adults with alopecia totalis and universalis.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.